#VisualAbstract: Addition of pembrolizumab to chemotherapy improves survival in patients with advanced esophageal carcinomas
Click to read the study in The Lancet.
Tag: head and neck cancer
#VisualAbstract: Post-induction chemotherapy Epstein-Barr virus DNA is an effective prognostic indicator for nasopharyngeal carcinomas
Click to read the study in the European Journal of Cancer.
#VisualAbstract: Concurrent S-1-based chemoradiotherapy improves survival compared to radiotherapy alone in older patients with esophageal cancer
Click to read the study in JAMA Oncology.
#VisualAbstract: Reduced intensity chemotherapy improves quality of life without reducing survival in frail or elderly patients with gastroesophageal cancer
Click to read the study in JAMA Oncology.
#VisualAbstract: Camrelizumab plus gemcitabine and cisplatin improves progression-free survival in patients with recurrent or metastatic nasopharyngeal carcinoma
Click to read the study in The Lancet Oncology.
#VisualAbstract: Development of pharyngocutaneous fistulas after salvage laryngectomy is associated with an increased risk of distant metastasis
Click to read the study in JAMA Otolaryngology Head & Neck Surgery.
#VisualAbstract: Induction chemotherapy does not improve survival for patients receiving chemoradiotherapy for esophageal squamous cell carcinoma
Click to read the study in Nature Communications.
#VisualAbstract: 18-F fluorodeoxyglucose positron emission tomography offers a high negative predictive value for detection of cervical lymph node metastases
Click to read the study in JAMA Network Open.
Adjuvant metronomic capecitabine improves survival in patients with locoregionally advanced nasopharyngeal carcinoma
1. Adjuvant capecitabine resulted in fewer instances of disease recurrence and death compared to standard therapy. 2. Overall and failure-free ...
#VisualAbstract: Induction chemotherapy may improve survival in patients with esophageal adenocarcinoma
Click to read the study in the European Journal of Cancer.
